Adderall XR Dosage Ranges
The FDA-approved dosage ranges for Adderall XR are 5-30 mg/day for children (ages 6-12), 10-40 mg/day for adolescents weighing ≤75 kg/165 lbs, and 20-60 mg/day for adults and adolescents weighing >75 kg/165 lbs 1.
Age-Specific Dosing
Children (Ages 6-12 Years)
- Approved range: 5-30 mg/day 1
- Start at 5-10 mg once daily in the morning
- Titrate in 5-10 mg increments weekly based on response
- Recent dose-effect meta-analysis shows peak efficacy at approximately 25 mg/day for amphetamines, with no additional benefit and potential reduced efficacy at higher doses 2
Adolescents (Ages 13-17 Years)
- If ≤75 kg (165 lbs): 10-40 mg/day 1
- If >75 kg (165 lbs): 20-60 mg/day 1
- The 2026 Lancet Psychiatry dose-effect network meta-analysis found that in adolescents, amphetamines showed increasing efficacy up to 25 mg/day with a plateau thereafter 2
Adults
- Approved range: 20-60 mg/day 1
- Clinical trials have demonstrated efficacy across this range 3
- The most recent dose-effect analysis (2026) showed amphetamines reach a plateau above approximately 50 mg/day in adults, with no compelling evidence for routine use of doses exceeding FDA-licensed maxima 2
Critical Dosing Principles
Avoid subtherapeutic dosing. Real-world data shows a substantial proportion of patients, especially children and adolescents, receive inadequate doses without appropriate upward titration 2. This leads to reduced clinical benefits and poor adherence. When symptoms remain insufficiently controlled, clinicians should not hesitate to titrate upward from minimal doses 2.
Do not routinely exceed FDA maximum doses. The 2026 Lancet Psychiatry network meta-analysis—the highest quality evidence available—found no evidence that escalation beyond licensed maximum doses improves mean efficacy at the patient-group level, and such increases are typically associated with reduced tolerability 2. While some individuals might require higher-than-licensed doses, any potential benefit must be carefully weighed against safety concerns 2.
Titration Strategy
- Start low: Begin at the lower end of the age-appropriate range
- Titrate weekly: Increase in 5-10 mg increments for children, 10-20 mg for adults
- Target optimal dose: For most patients, this falls within the middle-to-upper range of FDA-approved dosing
- Monitor response: Assess both efficacy and tolerability at each dose adjustment
- Stop at plateau: Once maximum benefit is achieved, further increases provide no additional benefit and worsen tolerability 2
Common Pitfalls to Avoid
- Underdosing: Particularly common in children and adolescents, leading to inadequate symptom control and treatment discontinuation 2
- Excessive dose escalation: Pushing beyond 25-30 mg/day in children or 50-60 mg/day in adults without clear benefit 2
- Ignoring tolerability: Higher doses are associated with increased adverse events including insomnia, decreased appetite, and cardiovascular effects 1
- Inadequate monitoring: Vital signs should be monitored before and during treatment, as small but statistically significant increases in blood pressure and heart rate occur 4, 5
Special Populations
Preschool children (ages 4-5): Adderall XR is not FDA-approved for this age group. If considering off-label use for moderate-to-severe ADHD unresponsive to behavioral therapy, use lower starting doses and smaller titration increments due to slower metabolism 6.
Adolescents with driving concerns: Consider longer-acting formulations or late-afternoon short-acting medications to provide symptom coverage during driving hours 6.
Adults with substance use disorders: Higher doses (60-80 mg/day) have been studied in comorbid ADHD and cocaine use disorder with some efficacy, but this requires specialized monitoring 7, 8.
Duration of Effect
Adderall XR provides approximately 12 hours of symptom control in adults, with peak plasma concentrations occurring around 7 hours post-dose 1, 3. This extended duration eliminates the need for midday dosing and improves adherence compared to immediate-release formulations.